Midazolam nasal spray for treatment of epilepsy (seizure clusters)
Midazolam is approved by the FDA in the United States to be given by an injection in the vein or muscle. In this study a spraying device will be used to spray midazolam in the nose. The purpose of this study is to learn more about how safe intranasal midazolam ...
Investigational Drug Study for Partial Seizures (YKP3089)
This research study is designed to evaluate the safety of an investigational drug called YKP3089 and to help researchers understand how YKP3089 and other anti-epileptic drugs affect each other in the body when taken together.
An Exploratory Case-Control Study of Genetic and Clinical Factors For Serious Cutaneous Reactions Among Users of Eslicarbazepine Acetate
Eslicarbazepine acetate (Aptiom®) is an antiepileptic drug (AED) approved in the United States (US) as adjunctive therapy for the treatment of partial-onset seizures in adults .Prior research has shown that seizure medicines like carbamazepine (Tegretol®) and oxcarbazepine (Trileptal®, Oxtellar®) are more likely to cause severe drug related skin reactions in ...